ABSTRACT To take advantage of the various pharmacologic activities of soy bean isoflavones, more detailed studies of the absorption and excretion rates of these compounds in humans and subsequent evaluation of their bioavailabilities are required. We conducted a pharmacokinetic study of soybean isoflavones in seven healthy male volunteers. After ingestion of 60 g of kinako (baked soybean powder, containing 103 mmol daidzein and 112 mmol genistein), changes of the isoflavone and metabolite concentrations in plasma, urine and feces were measured by gas chromatography-mass spectrometry. The plasma concentration of genistein increased after 2 h and reached its highest value of 2.44 { 0.65 mmol/L 6 h later. The plasma concentration of daidzein peaked at 1.56 { 0.34 mmol/L at the same time, but it was always lower than that of genistein. Peak plasma concentration of O-desmethylangolensin (O-DMA) and equol appeared after the daidzein peak in four and two subjects, respectively. In contrast with plasma, daidzein was the main component in urine. Urinary daidzein excretion started to increase shortly after the rise in its plasma concentration and reached 2.4 mmol/h 8 h after ingestion of kinako. Genistein excretion in urine paralleled that of daidzein, but the value at 6 h was about half (1.1 mmol/h). The majority of ingested isoflavones after ingestion of kinako were recovered on d 2 or 3 in the feces. Total recovery of daidzein, O-DMA and equol from urine and feces was 54.7%, calculated from daidzein intake; 20.1% of administered genistein was recovered as genistein. The half-lives of plasma genistein and daidzein were 8.36 and 5.79 h, respectively. The individual plasma and urinary concentrations of equol and O-DMA were quite variable; subjects were classified as high and low metabolizers. The high plasma concentration of isoflavones for at least several hours after a single ingestion of soy protein suggests that these compounds may interact with macromolecules and have biological effects.
There is interest in the various pharmacological effects of from breast, endometrial, ovarian and prostatic cancers in the soy isoflavones such as genistein and daidzein because of their Japanese population (Adlercreutz 1990 , Watanabe and Koessel potential role in the prevention of estrogen-related cancers 1993). and some diseases caused by estrogen deficiency (Adlercreutz Only one pharmacokinetic study has been conducted in et al. 1982 al. , 1986 al. , 1991a al. and 1995a al. , Braezinski et al. 1996 , which isoflavones were measured in human subjects simultane- Fotsis et al. 1993 , Messina et al. 1994 , Setchell et al. 1984 ously in plasma, urine and feces (Xu et al. 1994) . In that study, Watanabe and Koessel 1993, Wei et al. 1995) . The Japanese genistein and daidzein, but no metabolites, were determined consume Ç70 g soybean per capita per day as assessed by the by high performance liquid chromatography (HPLC) 4 . HutchNational Dietary Survey in 1995. Such high levels of soybean ins et al (1995) determined the metabolites O-desmethylangoproducts in Japanese diets result in high plasma and urine lensin (O-DMA) and equol in addition to genistein and daidconcentrations of daidzein and genistein and their metabolites zein in urine after intake of fermented and unfermented soy (Adlercreutz et al. 1991a and . We hypothesized that foods, but no analyses were done in blood or feces. King et these high levels may be responsible for the low mortality al. (1996) studied the pharmacokinetics of pure genistein or genistein after administration of a soy extract to rats and followed genistein concentrations in plasma, urine and feces
After centrifugation of tubes at 2000 1 g for 10 min at 4ЊC, 4 mL of plasma was separated and stored at 080ЊC for later measurement of isoflavones. Urine samples. A 24-h urine sample (from the second urination of the day to the first urination on the next day) was collected using the U-mate (24-h urine measuring device with proportional sampling method, Sumitomo Bakelite, Akita, Japan). Vitamin C (final concentration Ç10 g/L) and NaN 3 (final concentration 0.003 mol/L)(Sigma, Tokyo, Japan) were added to the storage bottle of U-mate to prevent isoflavone oxidation and bacterial contamination. On d 4, each urine sample was separately stored and labeled for time and volume. Each person urinated 6-8 times on that day. About 10 mL of urine were stored in a bottle at 080ЊC until assayed.
Feces. Feces were collected for 3 d, from the morning of d 5 to d 7. One gram of indigo carmine (Sigma) was consumed when the subject ingested the kinako so that defecation of meals containing kinako could be confirmed by the red color of the stools. All subjects had regular daily bowel movements. After homogenizing the stool, samples (Ç60 g) were stored in two bottles at 080ЊC. sinki. The samples were sent frozen in a dry-ice container. Plasma daidzein, genistein, O-DMA, equol, enterolactone and enterodiol were measured by isotope dilution capillary gas chromatography-mass
In soy products, isoflavones occur to a variable extent as spectrometry using selected ion monitoring with a slight modification glycosides (Brown 1988, Eldridge and Kwolek 1983) . This may of a method described in detail (Adlercreutz et al. 1994) . The samples affect absorption because the glycosidic bond is first split in the upper colon . In rats, however, the overall recovery of genistein seems to be independent of glycosidation (King et al. 1996) .
In this study, a more detailed pharmacokinetic evaluation was conducted in seven healthy Japanese men after consumption of a single dose of baked soybean powder (kinako). The isoflavone content of the kinako was carefully measured and the metabolism of the isoflavones followed for 3 d by measuring genistein, daidzein, O-DMA and equol, as well as enterolactone and enterodiol, in plasma, urine and feces by isotope dilution gas chromatography-mass spectrometry in the selected ion monitoring mode.
MATERIALS AND METHODS

Subjects.
Seven healthy men participated in this study after giving their written informed consent. Their ages ranged from 23 to 54 y (mean: 33.3 y, median: 30 y). Body height ranged from 165 to 178 cm (median: 171 cm), and body weights from 60 to 81 kg (median: 70 kg). The study design was approved by the ethics committee of the National Institute of Health and Nutrition of Japan. The participants remained in the dormitory of the institute from d 4 to 6, and ate specially prepared meals. Their usual daily movements and light sports were not restricted during this experiment.
Food and kinako supply. The participants were requested to consume a soy product-free diet 6 d before and throughout the 10-d study period. They were requested to strictly avoid tofu, natto (fermented soybean), miso (fermented soybean paste) and shoyu (soy sauce). We also requested that lignan-rich foods, such as rye bread, whole grain bread, oatmeal, beer, bourbon whiskey and soba noodles, be avoided. All foods and beverages were measured and reported in dietary records, and the dietary records were checked by trained dieticians. On the morning of d 4, 60 g of kinako (baked soybean powder) (Nisshin Seifun, Tokyo, Japan) dissolved in 200 g of 30 g/L agar water was added to the subjects breakfast. From d 4 to 6, meals adjusted to the energy requirement of each subject were provided by the dietitian. Energy requirements were calculated according to the height, weight and physical activity of the individuals based on the Recommended Dietary Allowance for Japanese (1995) . Breakfast time was 0700 h, lunch time 1200 h and dinner time 1800 h. Blood samples. Blood (8 mL) was collected in vacuum syringes containing heparin powder every day at 1100 h. On d 4, blood was FIGURE 3 Urinary daidzein and genistein excretion after ingestion in men of 60 g kinako. Each point the the mean { SD, n Å 7.
were purified by ion exchange chromatography. Instead of separating the sulfate and free fraction from the glucuronide fraction, the sulfates and glucuronides were hydrolyzed in consecutive steps and all free phytoestrogens were extracted with diethyl ether. The interassay coefficient of variation varied from 8.7 to 13.6% for all compounds occurring at concentrations ú0.01 mmol/L. The methods for assaying total urinary and unconjugated fecal isoflavonoids and lignans as well as the assay for phytoestrogens in food have been described in detail, including complete documentation of reliability (Adlercreutz et al. 1991b and 1995b , Mazur et al. 1996 . Four different portions of kinako agar gel were measured in duplicate, and the average concentrations of the isoflavones were used for calculation of ingested doses (103 mmol daidzein and 112 mmol genistein).
Because the lignan levels in plasma and urine were very low throughout this experiment, these values were not included. The halflives of plasma isoflavones were calculated by the equation, dS(/)/dt FIGURE 5 Different patterns of urinary daidzein, genistein, O-des-Å 0ldt, by using data from the highest average concentration (6 h methylanglolensin (O-DMA) and equol excretion in seven men after after kinako intake) to the value 48 h later. T (half-life) was given by T ingestion of 60 g kinako (baked soybean powder).
Å log2/l. Values in the text are means { SD, n Å 7.
RESULTS
( Fig. 1) . Genistein reached 3.76 mmol/L in subject 2, but the Plasma isoflavones and equol. Genistein levels were Ç0 mean concentration was 2.44 { 0.65 mmol/L. A few subjects after subjects avoided soybeans and soy products for 6 d. The showed a second peak or shoulder 12 h after ingestion. The highest mean level occurred at 6 h after ingestion of kinako genistein concentration had decreased to the basal level after 48 h, but a few subjects showed a slight elevation of the values above basal levels even 48 or 72 h later (Fig. 2) . The mean peak plasma daidzein concentration was lower than that of genistein (1.56 { 0.34 mmol/L). In subjects 1 and 7, however, daidzein concentration was as high as that of genistein. The plasma O-DMA concentration increased after the increase of daidzein concentration in subjects 1, 3, 4 and 7, and equol level increased only in subjects 6 and 7 (Fig. 2) .
Urinary excretion of isoflavones and equol. Daidzein and genistein excretions reached a plateaue from 8 to 12 h after kinako intake (Fig. 3) . Urinary genistein excretion paralleled daidzein excretion, but the value was about half that of daidzein. Excretion of daidzein began to rise shortly after the increase in its plasma level and reached a mean value of 2.4 mmol/h 7 h after kinako intake. Urinary excretion of genistein was highest at 8 h (1.2 mmol/h). The cumulative excreted 19.7 { 14.0 mmol (Fig. 4) . Excretion of O-DMA increased of 60 g kinako (baked soybean powder). ''Metabolizers'' excreted meafter the peak daidzein excretion in subjects 1,3,4 and 7 ( it occurred several hours after the peak daidzein excretion.
30, that of genistein ranged from 4 to 50, that of O-DMA ranged from 0.5 to 11.8 and that of equol ranged from 0.7 to These metabolites were quite low in subjects 1-5; thus they were categorized as ''low metabolizers.'' The excretion of these 6.4 in the individual subjects ( Table 1) . Absorbed and excreted amount of isoflavones. The 60-g metabolites was õ1 % of ingested daidzein. Characteristically, almost all subjects showed two or three, more or less clear kinako sample contained 103 mmol daidzein and 112 mmol genistein after hydrolysis of the glycosides. The amounts of peaks of daidzein and genistein excretion over the 2 d (Fig.  5) . In Subjects 1, 2, 3, 4 and 6, daidzein and genistein urinary the other isoflavones were negligible in the kinako. The mean recovery rate of daidzein in urine was 35.8%, and the metabolic excretions showed several peaks. Urinary O-DMA appeared a few hours later in urine. In subject 6, daidzein and genistein conversions of daidzein to O-DMA and equol were 4.0 and 7.0%, respectively (Table 1 ). The recovery in feces was 4.4% produced a second lower peak 13-14 h after kinako intake, and equol rapidly increased after the first peak of daidzein of ingested daidzein for daidzein, 1.9% for O-DMA and 1.6% for equol. The recovery rate of genistein in urine and feces excretion.
Feces. All seven subjects excreted stools every morning was 17.6 and 1.6%, respectively. The half-lives of plasma genistein and daidzein were calcuafter breakfast, and marker color was detected in the feces mainly on d 4, 24 h after kinako ingestion. O-DMA was the lated from the equation dS/dt Å 0lt. Isoflavone concentrations from the highest plasma concentration to that 48 h later main compound in d-4 stool after kinako ingestion in subject 4, but daidzein and genistein were dominant in d-7 stools in were used for calculations. Regression equations for genistein and daidzein, calculated from highest peak to lowest point, subject 2,4 and 5. Equol was predominant in the stools of subjects 6 and 7 (Fig. 6) . The ratio of the total amount of were y (mmol/L) Å 00.036x (h) / 3.593 (R 2 Å 1.000) and y Å 00.052x / 3.481 (R 2 Å 0.994), respectively. The half-lives daidzein excreted in urine to that in feces ranged from 5 to al. 1993, Yueh and Chu 1977) , and it has been suggested that equol is also a metabolite of genistein . Soybeans contain high amounts of genistein and daidzein Because many other metabolites occur that were not measured (Eldridge and Kwolek 1983 , Walter 1941 in this study , Kelly et al. 1993 , and Murphy 1994). In this study, the 60 g of baked soybean recovery, particularly of the daidzein administered, would be powder contained slightly less genistein (103 mmol Å 27.8 at least 60-70% if all metabolites could be measured. mg) than daidzein (112 mmol Å 28.5 mg). In the study by Xu
Most of the isoflavonoids in plasma occur in their glucuroet al. (1994) , the soy milk given to women contained much nide form (Adlercreutz et al. 1993 ), but small amounts also larger amounts of isoflavonoids, and the relative amount of occur as sulfates. In addition, sulfoglucuronides and disulfates daidzein was higher, which may explain the similar peak levels occur in urine (Adlercreutz et al. 1995c ) but at much lower of plasma daidzein and genistein in that study. In our experilevels than the monoconjugates. It has been shown that in ence, when similar amounts of genistein and daidzein are humans, estrogen sulfates are taken up by the liver and exgiven, the genistein concentration in plasma is almost always creted mainly as glucuronides in the bile (Adlercreutz 1962); higher than the daidzein concentration (Fig. 2) . In this study, the metabolism of isoflavones is likely similar. as in the study by Xu et al. (1994) , the urinary daidzein excreWe conclude that genistein, the most interesting isoflavone tion was much higher than that of genistein. In their first from an anticancer point of view (Adlercreutz et al. 1987 and study, Xu et al. (1994) found that only 1-2% of the isoflavones 1991a, Mazur 1997, Fotsis et al. 1993) , is ingested were excreted in the feces. In this study, 2.9% (0.2-the most important isoflavone in plasma of the subjects that 7.14 mmol) of the genistein ingested and 4.6% (1. 07-12.6 consumed the soy products, because it reached the highest mmol) of the daidzein were found in the feces. Average urinary concentration and had the longest half-life. This is advantarecovery of daidzein and genistein was 21 and 9% in the study geous from the point of view of preventive medicine. Because by Xu et al. (1994) , respectively, as opposed to 35.8 and 17.6%, the plasma levels of genistein decrease relatively rapidly, the respectively, in this study. When all metabolites of daidzein traditional custom in Japanese populations of consuming soy and the total amounts recovered in urine and feces were calcuproducts both morning and evening, a total of about 40 mg lated in this study, the total recovery of daidzein was 54.7% of isoflavonoids a day (Watanabe et al.1997) , may be imand that of genistein was 20.1%. In a later study, Xu et al.
portant in the prevention of cancer. (1995) found that the individual variation in fecal excretion was large, and that in some subjects it was 10-20 times higher LITERATURE CITED than in others. The recovery of isoflavones in urine and the plasma levels in those cases were also much higher, similar to our own values in this study. They concluded that the break- to the urine may depend on the different composition of intesAdlercreutz, H., Fotsis, T., Bannwart, C., Wä hä lä , K., Brunow, G. & Hase, T. (1991a) Isotope dilution gas chromatographic-mass spectrometric method tinal microflora. We tentatively categorized them as metabofor the determination of lignans and isoflavonoids in human urine, including lizer and nonmetabolizer. Karr et al. (1997) found that urinary identification of genistein. Clin. Chim. Acta 199: 263-278.
isoflavone excretion was dose dependent in both equol-excre- isoflavone levels to very low values after 6 d ( Fig. 1 ), but some likely due to absorption in the upper gastrointestinal tract of
